Artificial multi-enzyme cascades bear great potential for bioconversion of C1 compounds to value-added chemicals.Over the past decade,massive efforts have been devoted to constructing multi-enzyme cascades to produce ...Artificial multi-enzyme cascades bear great potential for bioconversion of C1 compounds to value-added chemicals.Over the past decade,massive efforts have been devoted to constructing multi-enzyme cascades to produce glycolic acid,rare functional sugars and even starch from C1 compounds.However,in contrast to traditional fermentation utilizing C1 compounds with the expectation of competitive economic performance in future industrialization,multi-enzyme cascades systems in the proof-of-concept phase are facing the challenges of upscaling.Here,we offered an overview of the recent advances in the construction of in vitro multi-enzyme cascades and whole-cell transformation using C1 compounds as substrate.In addition,the existing challenges and possible solutions were also discussed aiming to combine the strengths of in vitro and in vivo multi-enzyme cascades systems for upscaling.展开更多
Methanol is an attractive C1 feedstock with high abundance and low cost in bio-manufacturing.However,the metabolic construction of cell factories to utilize methanol for chemicals production remains a challenge due to...Methanol is an attractive C1 feedstock with high abundance and low cost in bio-manufacturing.However,the metabolic construction of cell factories to utilize methanol for chemicals production remains a challenge due to the toxic intermediates and complicated metabolic pathways.The group of Zhou rescued methylotrophic yeast from cell death and achieved high-level production of free fatty acids from methanol through a combination of adaptive laboratory evolution,rational metabolic engineering and multi-omics analysis.展开更多
基金supported by National Key R&D Program of China(2022YFC2105900)the National Natural Science Foundation of China(22078151,22378199,21978130)+1 种基金Jiangsu Natural Science Fund for Distinguished Young Scholars(BK20220052)the Jiangsu Synergetic Innovation Center for Advanced Bio-Manufacture(XTD2215)Young Elite Scientist Sponsorship Program by CAST(YESS20200174).
文摘Artificial multi-enzyme cascades bear great potential for bioconversion of C1 compounds to value-added chemicals.Over the past decade,massive efforts have been devoted to constructing multi-enzyme cascades to produce glycolic acid,rare functional sugars and even starch from C1 compounds.However,in contrast to traditional fermentation utilizing C1 compounds with the expectation of competitive economic performance in future industrialization,multi-enzyme cascades systems in the proof-of-concept phase are facing the challenges of upscaling.Here,we offered an overview of the recent advances in the construction of in vitro multi-enzyme cascades and whole-cell transformation using C1 compounds as substrate.In addition,the existing challenges and possible solutions were also discussed aiming to combine the strengths of in vitro and in vivo multi-enzyme cascades systems for upscaling.
基金This work was supported by National Key R&D Program of China(2018YFA0901500)the National Natural Science Foundation of China(22078151,21978130)+1 种基金Young Elite Scientist Sponsorship Program by CAST(YESS20200174)Jiangsu Synergetic Innovation Center for Advanced Bio-Manufacture.
文摘Methanol is an attractive C1 feedstock with high abundance and low cost in bio-manufacturing.However,the metabolic construction of cell factories to utilize methanol for chemicals production remains a challenge due to the toxic intermediates and complicated metabolic pathways.The group of Zhou rescued methylotrophic yeast from cell death and achieved high-level production of free fatty acids from methanol through a combination of adaptive laboratory evolution,rational metabolic engineering and multi-omics analysis.